drugset / Trial / NCT03038646
A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects
RandomizedCrossoverOpen-labelOther
Summary
* To evaluate the pharmacokinetic (PK) profiles of MIN-l0l following administration of modified release (MR) formulations of MIN-l0l in healthy male and female subjects * To select 1 MR formulation for use in fed state * To evaluate the effect of food on the bioavailability of MIN-l0l selected MR formulation
Timeline
- Start
- 2016-11-30
- Primary completion
- 2017-04-20
- Completion
- 2017-04-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Roluperidone | Small molecule | 32 mg | — |
Indications
No indication recorded.